Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Application and evaluation of nucleic acid sequence-based amplification, PCR and cryptococcal antigen test for diagnosis of cryptococcosis

Fig. 2

Electrophoresis analysis of NASBA products with gradient C. neoformans spores. M: DL1000bp DNA marker; 1–3: RNA extracted from the spore suspension of C. neoformans at a concentration of 106 CFU/mL, 105 CFU/mL, and 104 CFU/mL, which was used as a template for NASBA; 4–7: RNA extracted from the spore suspension with a concentration of 104 CFU/mL was diluted 10–10,000 times, and the concentrations corresponded to electrophoresis bands of 103 CFU/mL, 102 CFU/mL, 101 CFU/mL, and 100 CFU/mL, respectively

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us